Fortress Biotech shares are trading lower by 20% Friday afternoon. The company announced the pricing of a $8 million registered direct offering and concurrent private placements.

The completion of the Proposed Transaction is subject to the fulfilment, or waiver, of certain conditions, including board approvals, regulatory approvals, a satisfactory due diligence process, and ...

A surgeon makes small incisions in the eye, sucks out the cloudy lens and replaces it with an artificial lens implant.

An early-stage biotech investor called YK Bioventures plans to raise $100 million, according to an SEC filing on Wednesday.

Ginkgo Bioworks is pivoting: Once a synthetic biology darling, the flailing company has now turned to AI-driven protein ...

Discover how advances from various biotechs are bridging treatment gaps in menopause care, offering hope for managing ...

Those who graduate from the facility at Passaic County Technical Institute in Wayne will get associate’s degrees in ...

The 11000 Cedar Startup Incubator, formerly the home of BioEnterprise Inc., is poised to bridge the commercialization gap by ...

We recently compiled a list of the Jim Cramer’s Top 12 Must-Watch Stocks. In this article, we are going to take a look at ...

ASX health stocks have fallen this week but Morgans analyst Scott Power is more optimistic after the Fed cut the cash rate by ...

We recently published a list of 7 Best ASX Stocks To Invest In Right Now. In this article, we are going to take a look at ...

Earlier this week, we took a look at Argenica Therapeutics (ASX:AGN), a brain injury-focused clinical-stage biotech ...